ReP USP - Resultado da busca

Artigo de periodico
Tumor microenvironment of Hepatocellular Carcinoma: challenges and opportunities for new treatment options (2022)
Sas, Zuzanna; Cendrowicz, Ewa; Weinhäuser, Isabel; Rygiel, Tomasz P.
Source: International Journal of Molecular Sciences. Unidade: FMRP
Subjects: CARCINOMA HEPATOCELULAR, IMUNOTERAPIA, NEOPLASIAS, NEOPLASIAS HEPÁTICAS, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAS, Zuzanna et al. Tumor microenvironment of Hepatocellular Carcinoma: challenges and opportunities for new treatment options. International Journal of Molecular Sciences, v. 23, n. 7, p. 1-22, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23073778. Acesso em: 03 nov. 2024.
APA
Sas, Z., Cendrowicz, E., Weinhäuser, I., & Rygiel, T. P. (2022). Tumor microenvironment of Hepatocellular Carcinoma: challenges and opportunities for new treatment options. International Journal of Molecular Sciences, 23( 7), 1-22. doi:10.3390/ijms23073778
NLM
Sas Z, Cendrowicz E, Weinhäuser I, Rygiel TP. Tumor microenvironment of Hepatocellular Carcinoma: challenges and opportunities for new treatment options [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 7): 1-22.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/ijms23073778
Vancouver
Sas Z, Cendrowicz E, Weinhäuser I, Rygiel TP. Tumor microenvironment of Hepatocellular Carcinoma: challenges and opportunities for new treatment options [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 7): 1-22.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/ijms23073778
Artigo de periodico
Telomere length and risk of major adverse cardiac events and cancer in obstructive sleep apnea patients (2019)
Polonis, Katarzyna; Sompalli, Sreeja; Ribeiro, Christiane Becari; Xie, Jiang; Covassin, Naima; Schulte, Phillip J.; Druliner, Brooke R.; Johnson, Ruth A.; Narkiewicz, Krzysztof; Boardman, Lisa A.; Singh, Prachi; Somers, Virend K.
Source: Cells. Unidade: FMRP
Subjects: APNEIA DO SONO TIPO OBSTRUTIVA, TELÔMERO, DOENÇAS CARDIOVASCULARES, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POLONIS, Katarzyna et al. Telomere length and risk of major adverse cardiac events and cancer in obstructive sleep apnea patients. Cells, v. 8, n. 5, p. 1-12, 2019Tradução . . Disponível em: https://doi.org/10.3390/cells8050381. Acesso em: 03 nov. 2024.
APA
Polonis, K., Sompalli, S., Ribeiro, C. B., Xie, J., Covassin, N., Schulte, P. J., et al. (2019). Telomere length and risk of major adverse cardiac events and cancer in obstructive sleep apnea patients. Cells, 8( 5), 1-12. doi:10.3390/cells8050381
NLM
Polonis K, Sompalli S, Ribeiro CB, Xie J, Covassin N, Schulte PJ, Druliner BR, Johnson RA, Narkiewicz K, Boardman LA, Singh P, Somers VK. Telomere length and risk of major adverse cardiac events and cancer in obstructive sleep apnea patients [Internet]. Cells. 2019 ; 8( 5): 1-12.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/cells8050381
Vancouver
Polonis K, Sompalli S, Ribeiro CB, Xie J, Covassin N, Schulte PJ, Druliner BR, Johnson RA, Narkiewicz K, Boardman LA, Singh P, Somers VK. Telomere length and risk of major adverse cardiac events and cancer in obstructive sleep apnea patients [Internet]. Cells. 2019 ; 8( 5): 1-12.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/cells8050381
Trabalho de evento-resumo periodico
Comprehensive analysis of cancer stemness (2018)
Malta, Tathiane M.; Sokolov, Artem; Gentles, Andrew J.; Burzykowski, Tomasz; Poisson, Laila; Weinstein, John; Kaminska, Bozena; Huelsken, Joerg; Omberg, Larsson; Gevaert, Olivier; Noushmehr, Houtan
Source: Cancer Research. Conference titles: Annual Meeting of the American Association for Cancer Research (AACR). Unidade: FMRP
Subjects: NEOPLASIAS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane M. et al. Comprehensive analysis of cancer stemness. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2018-LB-373. Acesso em: 03 nov. 2024. , 2018
APA
Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J., et al. (2018). Comprehensive analysis of cancer stemness. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2018-LB-373
NLM
Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein J, Kaminska B, Huelsken J, Omberg L, Gevaert O, Noushmehr H. Comprehensive analysis of cancer stemness [Internet]. Cancer Research. 2018 ; 78( 13):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1158/1538-7445.AM2018-LB-373
Vancouver
Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein J, Kaminska B, Huelsken J, Omberg L, Gevaert O, Noushmehr H. Comprehensive analysis of cancer stemness [Internet]. Cancer Research. 2018 ; 78( 13):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1158/1538-7445.AM2018-LB-373
Artigo de periodico
Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk (2015)
Spina, M.; Nagy, Z.; Ribera, J. M.; Federico, M.; Aurer, I.; Jordan, K.; Borsaru, G.; Pristupa, A. S.; Bosi, A.; Grosicki, S.; Glushko, N. L.; Ristic, D.; Jakucs, J.; Montesinos, P.; Mayer, J.; Rego, Eduardo Magalhães; Baldini, S.; Scartoni, S.; Capriati, A.; Maggi, C. A.; Simonelli, C.
Source: Annals of Oncology. Unidade: FMRP
Subjects: NEOPLASIAS, HEMATOLOGIA, RIM, ÁCIDO ÚRICO, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPINA, M. et al. Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. Annals of Oncology, v. 26, n. 10, p. 2155-2161, 2015Tradução . . Disponível em: https://doi.org/10.1093/annonc/mdv317. Acesso em: 03 nov. 2024.
APA
Spina, M., Nagy, Z., Ribera, J. M., Federico, M., Aurer, I., Jordan, K., et al. (2015). Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. Annals of Oncology, 26( 10), 2155-2161. doi:10.1093/annonc/mdv317
NLM
Spina M, Nagy Z, Ribera JM, Federico M, Aurer I, Jordan K, Borsaru G, Pristupa AS, Bosi A, Grosicki S, Glushko NL, Ristic D, Jakucs J, Montesinos P, Mayer J, Rego EM, Baldini S, Scartoni S, Capriati A, Maggi CA, Simonelli C. Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk [Internet]. Annals of Oncology. 2015 ; 26( 10): 2155-2161.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1093/annonc/mdv317
Vancouver
Spina M, Nagy Z, Ribera JM, Federico M, Aurer I, Jordan K, Borsaru G, Pristupa AS, Bosi A, Grosicki S, Glushko NL, Ristic D, Jakucs J, Montesinos P, Mayer J, Rego EM, Baldini S, Scartoni S, Capriati A, Maggi CA, Simonelli C. Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk [Internet]. Annals of Oncology. 2015 ; 26( 10): 2155-2161.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1093/annonc/mdv317

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration